Outcome after nitinol stenting in the superficial femoral and popliteal artery in an elderly population

Annals of Vascular Surgery

Volumn 25, Issue 6, 2011, Pages 758-765

  Gillgren, Peter ^a   Pettersson, Hans ^a   Fernström, Johan ^a   Falkenberg, Mårten ^b   Delle, Martin ^a   Konrad, Peter ^a   Lindström, David ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITINOL; WARFARIN;

AGED; AMPUTATION; ARTICLE; CLAUDICATION; CONTROLLED STUDY; DEATH; ELDERLY CARE; FEMALE; GRAFT PATENCY; HUMAN; LIMB; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OCCLUSION; OUTCOME ASSESSMENT; PAIN; POPLITEAL ARTERY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STENT; SUPERFICIAL FEMORAL ARTERY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; FEMORAL ARTERY; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; MALE; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 79960979186     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2010.12.010     Document Type: Article

References (22)

1. DeRubertis BG, Faries PL, McKinsey JF, et al. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1,000 percutaneous interventions. Ann Surg 2007;246:415-422. discussion 22-24.
2. Surowiec SM, Davies MG, Eberly SW, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005;41:269-278. (Pubitemid 40342478)
3. Ferreira M, Lanziotti L, Monteiro M, et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg 2007;34:702-708. (Pubitemid 350056379)
4. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888. (Pubitemid 43872689)
5. Dick P, Wallner H, Sabeti S, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009;74: 1090-1095.
6. Mwipatayi BP, Hockings A, Hofmann M, et al. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis. J Vasc Surg 2008;47:461-469. (Pubitemid 351172652)
7. Twine CP, Coulston J, Shandall A, et al. Angioplasty versus stenting for superficial femoral artery lesions. Cochrane Database Syst Rev (Online) 2009;CD006767.
8. Minar E, Schillinger M. New stents for SFA. J Cardiovas Surg 2009;50:635-645.
9. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther 2009;16:261-269.
10. Schmieder GC, Richardson AI, Scott EC, et al. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes. J Vasc Surg 2008;48:1175-1180. discussion 80-81.
11. Davies MG, Saad WE, Peden EK, et al. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg 2008;48:619-625. discussion 25-26.
12. DeRubertis BG, Vouyouka A, Rhee SJ, et al. Percutaneous intervention for infrainguinal occlusive disease in women: equivalent outcomes despite increased severity of disease compared with men. J Vasc Surg 2008;48:150-157. discussion 7-8.
13. Davies MG, Saad WE, Peden EK, et al. Percutaneous superficial femoral artery interventions for claudication - does runoff matter? Ann Vasc Surg 2008;22:790-798.
14. Ihnat DM, Duong ST, Taylor ZC, et al. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. J Vasc Surg 2008;47:967-974.
15. Dearing DD, Patel KR, Compoginis JM, et al. Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg 2009;50:542-547.
16. Zeller T, Tiefenbacher C, Steinkamp HJ, et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). J Endovasc Ther 2008;15:390-398.
17. Diehm N, Pattynama PM, Jaff MR, et al. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg 2008;36:409-419.
18. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-538. (Pubitemid 27408567)
19. Dormandy JA, Rutherford RB. TASC Working Group; Trans- Atlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). J Vasc Surg 2000;31(1 Pt. 2):S1-S296.
20. Wilson SE. Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients. Ann Vasc Surg 2010;24:498-502.
21. Baril DT, Rhee RY, Kim J, et al. Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2009;49: 133-138. discussion 9.
22. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl. 1): S1-S75. (Pubitemid 46068992)